{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:24:24Z","timestamp":1792297464975,"version":"4.4.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"abstract":"Summary<\/jats:title>\n \n Background and objectives<\/jats:title>\n Kidney disease is associated with physiologic changes that may predispose to frailty. This study sought to investigate whether lower levels of kidney function were associated with prevalent or incident frailty in Cardiovascular Health Study (CHS) participants.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n \n CHS enrolled community-dwelling adults age \u226565 years between 1989\u20131990 and 1992\u20131993. To examine prevalent frailty, included were 4150 participants without stroke, Parkinson disease, prescribed medications for Alzheimer disease or depression, or severely impaired cognition. To examine incident frailty, included were a subset of 3459 participants without baseline frailty or development of exclusion criteria during follow-up. The primary predictor was estimated GFR (eGFR) calculated using serum cystatin C (eGFR\n cys<\/jats:sub>\n ). Secondary analyses examined eGFR using serum creatinine (eGFR\n SCr<\/jats:sub>\n ). Outcomes were prevalent frailty and incident frailty at 4 years of follow-up. Frailty was ascertained on the basis of weight loss, exhaustion, weakness, slowness, and low physical activity.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The mean age was 75 years and the median eGFR\n cys<\/jats:sub>\n was 73 ml\/min per 1.73 m\n 2<\/jats:sup>\n . Among participants with an eGFR\n cys<\/jats:sub>\n <45 ml\/min per 1.73 m\n 2<\/jats:sup>\n , 24% had prevalent frailty. In multivariable analysis and compared with eGFR\n cys<\/jats:sub>\n \u226590 ml\/min per 1.73 m\n 2<\/jats:sup>\n , eGFR\n cys<\/jats:sub>\n categories of 45\u201359 (odds ratio [OR], 1.80; 95% confidence interval [CI], 1.17 to 2.75) and 15\u201344 (OR, 2.87; 95% CI, 1.72 to 4.77) were associated with higher odds of frailty, whereas 60\u201375 (OR, 1.14; 95% CI, 0.76 to 1.70) was not. In multivariable analysis, eGFR\n cys<\/jats:sub>\n categories of 60\u201375 (incidence rate ratio [IRR], 1.72; 95% CI, 1.07 to 2.75) and 15\u201344 (IRR, 2.28; 95% CI, 1.23 to 4.22) were associated with higher incidence of frailty whereas 45\u201359 (IRR, 1.53; 95% CI, 0.90 to 2.60) was not. Lower levels of eGFR\n SCr<\/jats:sub>\n were not associated with higher risk of prevalent or incident frailty.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n In community-dwelling elders, lower eGFR\n cys<\/jats:sub>\n was associated with a higher risk of prevalent and incident frailty whereas lower eGFR\n SCr<\/jats:sub>\n was not. These findings highlight the importance of considering non-GFR determinants of kidney function.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.02870313","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T04:01:41Z","timestamp":1383278501000},"page":"2091-2099","source":"Crossref","is-referenced-by-count":140,"title":["Kidney Function and Prevalent and Incident Frailty"],"prefix":"10.2215","volume":"8","author":[{"given":"Lorien S.","family":"Dalrymple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena E.","family":"Rifkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Siscovick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F.","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Odden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-10-20230811","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1681\/ASN.2005040384","article-title":"Kidney function as a predictor of noncardiovascular mortality.","volume":"16","author":"Fried","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R4-10-20230811","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1532-5415.2006.00727.x","article-title":"Chronic kidney disease and functional limitation in older people: Health, aging and body composition study.","volume":"54","author":"Fried","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"R5-10-20230811","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archinternmed.2007.40","article-title":"Cystatin C and aging success.","volume":"168","author":"Sarnak","year":"2008","journal-title":"Arch Intern Med"},{"key":"R6-10-20230811","first-page":"M146","article-title":"Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med","volume":"56","author":"Fried","year":"2001","journal-title":"Sci"},{"key":"R10-10-20230811","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The Cardiovascular Health Study: Design and rationale.","volume":"1","author":"Fried","year":"1991","journal-title":"Ann Epidemiol"},{"key":"R11-10-20230811","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/1047-2797(93)90062-9","article-title":"Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.","volume":"3","author":"Tell","year":"1993","journal-title":"Ann Epidemiol"},{"key":"R12-10-20230811","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/clinchem\/41.2.264","article-title":"Laboratory methods and quality assurance in the Cardiovascular Health Study.","volume":"41","author":"Cushman","year":"1995","journal-title":"Clin Chem"},{"key":"R13-10-20230811","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/1047-2797(94)00092-8","article-title":"Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.","volume":"5","author":"Psaty","year":"1995","journal-title":"Ann Epidemiol"},{"key":"R15-10-20230811","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R16-10-20230811","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R18-10-20230811","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2010050483","article-title":"Cystatin C identifies chronic kidney disease patients at higher risk for complications.","volume":"22","author":"Peralta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R19-10-20230811","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archinternmed.2012.3020","article-title":"Frailty, dialysis initiation, and mortality in end-stage renal disease.","volume":"172","author":"Bao","year":"2012","journal-title":"Arch Intern Med"},{"key":"R20-10-20230811","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1532-5415.2007.01398.x","article-title":"Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study.","volume":"55","author":"Fried","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"R21-10-20230811","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1532-5415.2006.00745.x","article-title":"Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society\/National Institute on Aging Research Conference on Frailty in Older Adults.","volume":"54","author":"Walston","year":"2006","journal-title":"J Am Geriatr Soc"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201312000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:46Z","timestamp":1786369426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201312000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02870313","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}